NCT06865898View on ClinicalTrials.gov

Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

Active, not recruitingOBSERVATIONAL

Enrollment

58

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

HBV Related Acute-on-chronic Liver Failure

Trial Locations (1)

250012

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

lead

Qilu Hospital of Shandong University

OTHER